ACST-2试验中支架与脑保护装置的选择:描述性研究
该研究基于正在进行的ACST-2试验,纳入2008至2015年间接受颈动脉支架置入术的831例患者,评估斑块与病变特征是否影响支架及脑保护装置的选择。结果显示斑块特征和狭窄严重程度并未主要决定介入医生的选择,而血管外科医生使用脑保护装置的比例显著高于介入放射科医生(98.6% vs. 76.3%,p < .001),各中心间选择差异较大。
要点
- 斑块特征和狭窄严重程度不影响支架或脑保护装置的选择。
- 血管外科医生使用脑保护装置的比例显著高于介入放射科医生。
- 支架和脑保护装置的使用在欧洲各中心间高度异质。
核心结论
- 在ACST-2中,斑块特征和狭窄严重程度未主要决定介入医生对支架或脑保护装置的选择。
- 血管解剖、个人及中心偏好等其他因素可能更为重要。
研究设计与样本
- 研究纳入2008至2015年间在88个ACST-2中心接受颈动脉支架置入术的831例患者。
- 采用卡方统计研究斑块回声透亮、同侧近闭塞病变(90-99%)及对侧高度狭窄(>50%)或闭塞对支架和脑保护装置选择的影响。
主要发现
- 几乎全部手术由介入放射科医生(50%)或血管外科医生(45%)完成。
- 斑块回声透亮、同侧近闭塞病变(90-99%)及对侧显著狭窄(>50%)或闭塞未影响支架选择或脑保护装置的使用及类型(滤网/血流逆转)。
- 血管外科医生使用脑保护装置显著多于介入放射科医生(98.6% vs. 76.3%;p < .001),但该选择似乎不依赖于患者特征。
临床怎么用
- 临床选择支架和脑保护装置时,应综合考虑血管解剖、个人及中心偏好等因素,而非仅依据斑块特征或狭窄严重程度。
- 不同专科医生间脑保护装置使用率存在显著差异,提示需关注实践异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE/BACKGROUND: Several plaque and lesion characteristics have been associated with an increased risk for procedural stroke during or shortly after carotid artery stenting (CAS). While technical advancements in stent design and cerebral protection devices (CPD) may help reduce the procedural stroke risk, and anatomy remains important, tailoring stenting procedures according to plaque and lesion characteristics might be a useful strategy in reducing stroke associated with CAS. In this descriptive report of the ongoing Asymptomatic Carotid Surgery Trial-2 (ACST-2), it was assessed whether choice for stent and use or type of CPD was influenced by plaque and lesion characteristics. METHODS: Trial patients who underwent CAS between 2008 and 2015 were included in this study. Chi-square statistics were used to study the effects of plaque echolucency, ipsilateral preocclusive disease (90-99%), and contralateral high-grade stenosis (>50%) or occlusion of the carotid artery on interventionalists' choice for stent and CPD. Differences in treatment preference between specialties were also analysed. RESULTS: In this study, 831 patients from 88 ACST-2 centres were included. Almost all procedures were performed by either interventional radiologists (50%) or vascular surgeons (45%). Plaque echolucency, ipsilateral preocclusive disease (90-99%), and significant contralateral stenosis (>50%) or occlusion did not affect the choice of stent or either the use of cerebral protection and type of CPD employed (i.e., filter/flow reversal). Vascular surgeons used a CPD significantly more often than interventional radiologists (98.6% vs. 76.3%; p < .001), but this choice did not appear to be dependent on patient characteristics. CONCLUSION: In ACST-2, plaque characteristics and severity of stenosis did not primarily determine interventionalists' choice of stent or use or type of CPD, suggesting that other factors, such as vascular anatomy or personal and centre preference, may be more important. Stent and CPD use was highly heterogeneous among participating European centres.
引用
- de Waard DD, Halliday A, de Borst GJ, et al. Choices of Stent and Cerebral Protection in the Ongoing ACST-2 Trial: A Descriptive Study. Eur J Vasc Endovasc Surg. 2017. PMID: 28291675. doi:10.1016/j.ejvs.2016.12.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。